Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
LSINW 2016 Women in Life Science
Share |

 

Life Science Innovation Northwest Women in Life Science Award

 Back to LSINW Home

 

This award recognizes those exceptionally talented, dynamic and inspirational women in the life sciences that we, as an industry, celebrate for their contributions in shaping the life science industry in the Pacific Northwest.

 
We are honored to have Caitlin Cameron, Chief Executive Officer of OtoNexus Medical Technologies as the emcee of our awards ceremony. View her Life Science TV interview HERE!

 

* Jane Buckner, MD | President, Benaroya Research Institute at Virginia Mason; Director, Translational Research Program | Jane Buckner is the President of the Benaroya Research Institute at Virginia Mason (BRI), the Director of Translational Research Program at the Benaroya Research Institute, and an affiliate Professor of Medicine in the Division of Rheumatology at the University of Washington. Dr. Buckner’s interdisciplinary research combines genetics, immunology and clinical medicine to advance our understanding of the causes of autoimmune diseases including type 1 diabetes, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and relapsing polychondritis. She has published over 100 peer-reviewed papers, and is funded by the National Institutes of Health (NIH), the Department of Defense, the Leona M. and Harry B. Helmsley Charitable Trust, and JDRF. She also has collaborations with Pfizer, Eli Lilly, Novo Nordisk and Bristol-Myers Squibb. Dr. Buckner also serves as the chair of the Cooperative Study Group for Autoimmune Disease Prevention at NIH, and is the Director of the North American Federation of Clinical Immunology Societies Center of Excellence in Seattle. Dr. Buckner received her bachelor’s degree in chemistry from Carleton College, and her medical degree from Johns Hopkins School of Medicine. She has been honored by the American College of Rheumatology, having received both their Senior Rheumatology Scholar award, and their Arthritis Investigator Award. View her Life Science TV Interview HERE!

 

* Charlotte Hubbert, PhD | Program Investment Officer | Gates Foundation Venture Capital, The Bill & Melinda Gates Foundation | Prior to joining the Gates Foundation, Charlotte was a Vice-President at H.I.G. BioVentures focusing on investment opportunities in the life sciences, including therapeutics, diagnostics and medical devices at all stages of development. She was BOD observer at Cardeas Pharma and Alder Biopharmaceuticals. Charlotte started her career in early stage biotech investing at Accelerator Corporation, an investment vehicle focused on identifying, evaluating, financing and managing emerging therapeutic technologies. During her tenure, Charlotte was involved in the strategic development and management of five companies, including Oncofactor, Groove Biopharma, Acylin Therapeutics, Xori and Pharmselex. Charlotte currently serves as an observer on the board of directors of Synlogic, Sera Prognostics and Lodo Therapeutics. Charlotte earned a B.S. in Microbiology from the University of Washington and a Ph.D. in Pharmacology and Cancer Biology from Duke University. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at the University of Washington. Charlotte is a member of the Kauffman Society of Fellows (Class 14). View her Life Science TV interview HERE!


* Margaret McCormick, PhD | Chief Executive Officer and Director | Matrix Genetics | Dr. McCormick was appointed to and currently serves on the Washington State Life Science Discovery Fund Board, Joint Center for Aerospace Technology Innovation Board, and the Washington State Life Science & Global Health Advisory Council.  She also is a director of the Algae Biomass Organization, the treasurer/ executive committee member of the Life Science Washington and an Associate Trustee of the Memorial Union Building Association.  Previously, she held positions with Targeted Growth, Inc., Integra Ventures, BCM Technologies and McKinsey & Company.  Dr. McCormick earned a Ph.D. in Biology from the Massachusetts Institute of Technology and a BS degree in Biochemistry and Molecular Biology from the University of Wisconsin – Madison. View her Life Science TV interview HERE


* Claudia Mitchell, PhD, MBA | Chief Executive Officer and Co-Founder | Universal Cells, Inc. | Claudia has previously co-founded Halo-Bio RNAi Therapeutics, a Seattle-based biotech start-up company developing new RNAi molecules, and served as its Chief Scientific Officer from 2008 to 2011. Besides being a biotech entrepreneur, Claudia has also held positions in the non-profit sector and in Academia; she worked as the Program Director at the LGMD2I Research Fund, a family non-profit foundation, and has held a tenured Academic research position at the French National Institute of Medical Research (INSERM). She received her PhD in Molecular Biology from the University of Paris and an MBA in International Management from the Ecole Nationale de Ponts et Chaussées, Paris, France. View her Life Science TV interview HERE

 

* Beverly Torok-Storb, PhD | Clinical Research Division | Fred Hutchinson Cancer Research Center | Wildly talented scientists can come from anywhere, including the most humble of beginnings. Dr. Beverly Torok-Storb, a longtime clinical researcher at Fred Hutchinson Cancer Research Center, grew up poor in a public-housing project in Erie, Pennsylvania. But thanks to extraordinary teachers and mentors, she rose through the scientific ranks to become a renowned transplantation biologist who’s played a key role in the development of bone marrow transplantation, a life-saving therapy for leukemia and other blood disorders. This therapy, developed at Fred Hutch but now used worldwide, has transformed cancers that were once universally fatal into curable illnesses. Early in her career, Torok-Storb proved stem cells in marrow can mature into cells of the blood and immune system but not into every type of cell in the body, as many researchers believed. Later, she demonstrated that supportive cells in the marrow are vital to the development of stem cells and transplant success. Today, Torok-Storb continues to unravel the complex signaling networks in the marrow microenvironment that regulate stem cells, discoveries that will continue to improve transplant methods and save lives in the future. She also remains a steadfast advocate and mentor for the next generation of researchers, particularly those from low income, disadvantaged and underrepresented backgrounds, via two high school scientific internship programs. “To watch [the students] change after they’ve been here for a while really gives me a sense of joy,” Torok-Storb said. “They become confident …They feel they belong and that they can do it. It’s really wonderful.” View her Life Science TV Interview HERE!

 

more Calendar

4/27/2017
2017 LSW Program: Next-Generation Therapeutics for the Treatment of Pain

5/15/2017
2017 Laboratory to Leadership - Spring

Featured Partners
BioTech Primer Inc.BioTech Primer develops and delivers customized training to the Life Sciences community

Membership Management Software Powered by YourMembership  ::  Legal